Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chia Tai Tianqing Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fosaprepitant dimeglumine
Fosaprepitant dimeglumine
2021-03-03
—
Fulvestrant
Fulvestrant
2020-02-07
2034
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fulvestrant
healthy volunteers/patients
,
uterine cervical neoplasms
,
pharmacokinetics
,
pharmacological phenomena
,
lung neoplasms
,
triple negative breast neoplasms
,
non-small-cell lung carcinoma
,
ovarian neoplasms
,
endometrial neoplasms
,
prostatic neoplasms
,
carcinoma
,
systemic lupus erythematosus
,
syndrome
,
precocious puberty
,
polyostotic fibrous dysplasia
,
carcinoma in situ
,
ductal carcinoma breast
,
ductal carcinoma
,
intraductal carcinoma noninfiltrating
,
pancreatic neoplasms
,
sarcoma
,
neoplasms
,
neoplasm metastasis
,
disease progression
,
male breast neoplasms
,
progression-free survival
,
breast neoplasms
,
postmenopause
Eribulin
breast neoplasms
,
neoplasms
Eribulin mesylate
lymphoma
,
skin neoplasms
,
cutaneous malignant melanoma
,
abdominal neoplasms
,
retroperitoneal neoplasms
,
renal insufficiency
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
lung neoplasms
,
prostatic neoplasms
,
liposarcoma
,
inflammatory breast neoplasms
,
melanoma
,
leiomyosarcoma
,
colorectal neoplasms
,
urethral neoplasms
,
ureteral neoplasms
,
renal cell carcinoma
,
fallopian tube neoplasms
,
head and neck neoplasms
,
ewing sarcoma
,
rhabdomyosarcoma
,
pancreatic neoplasms
,
pelvic neoplasms
,
colonic neoplasms
,
fatigue
,
circulating neoplastic cells
,
postmenopause
,
soft tissue neoplasms
,
malignant fibrous histiocytoma
,
residual neoplasm
,
solitary fibrous tumors
,
hemangiopericytoma
,
fibrous tissue neoplasms
,
hemangiosarcoma
,
epithelioid hemangioendothelioma
,
osteosarcoma
,
uterine cervical neoplasms
,
salivary gland neoplasms
,
castration-resistant prostatic neoplasms
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
hepatocellular carcinoma
,
drug therapy
,
triple negative breast neoplasms
,
neoplasms
,
sarcoma
,
neoplasm metastasis
,
recurrence
,
carcinoma
,
non-small-cell lung carcinoma
,
brain neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
urologic neoplasms
,
hereditary breast and ovarian cancer syndrome
,
adenocarcinoma
,
brca2 genes
,
invasive hydatidiform mole
,
meningeal neoplasms
,
meningeal carcinomatosis
,
mutation
,
breast neoplasms
,
male breast neoplasms
,
drug-related side effects and adverse reactions
,
neurotoxicity syndromes
,
peripheral nervous system diseases
,
alopecia areata
,
alopecia
Mycophenolate sodium
hyperlipoproteinemia type i
Benzimidazole
healthy volunteers/patients
,
multiple myeloma
,
b-cell chronic lymphocytic leukemia
,
plasma cell neoplasms
,
hematologic neoplasms
,
hodgkin disease
,
leukemia
,
neoplasms
,
lymphoma
,
non-hodgkin lymphoma
,
mantle-cell lymphoma
Sintilimab
non-small-cell lung carcinoma
,
lung neoplasms
Penpulimab
colorectal neoplasms
,
stomach neoplasms
,
squamous cell carcinoma of head and neck
,
pancreatic neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma
,
large b-cell lymphoma diffuse
,
gastrointestinal neoplasms
,
thyroid neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
,
recurrence
,
neoplasm metastasis
,
sarcoma
,
rectal neoplasms
,
pheochromocytoma
,
urologic neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
,
small cell lung carcinoma
,
female genital neoplasms
,
glioblastoma
,
uterine cervical neoplasms
,
neoplasms by histologic type
,
male breast neoplasms
,
essential tremor
,
head and neck neoplasms
,
syndrome
,
gastrointestinal diseases
,
digestive system diseases
,
paraganglioma
,
osteosarcoma
,
b-cell lymphoma
,
melanoma
,
esophageal neoplasms
,
adenocarcinoma
,
neoadjuvant therapy
,
immunotherapy
,
neoplasms
,
carcinoma
,
lung neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
lymphoma
,
hodgkin disease
,
squamous cell neoplasms
,
hypersensitivity
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
small cell carcinoma
,
thyroid diseases
Lanifibranor
healthy volunteers/patients
,
pharmacokinetics
,
type 2 diabetes mellitus
,
diabetes mellitus
,
liver diseases
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
non-alcoholic fatty liver disease
,
fatty liver
,
fibrosis
Gilvetmab
hiv infections
,
hiv-1
,
acquired immunodeficiency syndrome
,
hiv-2
,
immunologic deficiency syndromes
,
colorectal neoplasms
,
urinary bladder neoplasms
,
neoplasms
,
non-small-cell lung carcinoma
,
pancreatic neoplasms
,
neoplasm metastasis
,
squamous cell carcinoma of head and neck
,
carcinoma
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
Enoblituzumab
primary myelofibrosis
Efbemalenograstim alfa
neutropenia
,
non-small-cell lung carcinoma
,
lung neoplasms
,
febrile neutropenia
,
ovarian neoplasms
,
uterine cervical neoplasms
Aglatimagene besadenovec
prostatic neoplasms
,
neoplasms
,
leukemia
,
myelodysplastic syndromes
,
colorectal neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
myeloproliferative disorders
,
non-hodgkin lymphoma
,
primary myelofibrosis
,
multiple myeloma
,
glioblastoma
,
lymphoma
,
large b-cell lymphoma diffuse
,
hematologic neoplasms
,
castration-resistant prostatic neoplasms
,
adenocarcinoma
Spartalizumab
glioblastoma
,
cutaneous malignant melanoma
,
neoplasms by histologic type
,
neoplasms by site
,
brain neoplasms
,
gliosarcoma
,
melanoma
,
neoplasms
,
squamous cell carcinoma of head and neck
,
carcinoma
,
breast neoplasms
,
pancreatic neoplasms
,
head and neck neoplasms
,
lung neoplasms
,
sarcoma
,
lymphoma
,
bile duct neoplasms
,
liver neoplasms
,
colonic neoplasms
,
squamous cell carcinoma
,
squamous cell neoplasms
,
chordoma
,
non-small-cell lung carcinoma
,
nose neoplasms
Lenograstim
healthy volunteers/patients
,
neutropenia
,
breast neoplasms
,
chemotherapy-induced febrile neutropenia
Faropenem
tuberculosis
,
pulmonary tuberculosis
,
otitis media
,
otitis
,
community-acquired pneumonia
,
chronic bronchitis
,
bronchitis
,
acute disease
,
pneumonia
,
bacterial pneumonia
,
community-acquired infections
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use